Allscripts Announces Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Allscripts (MDRX) Tops Q2 EPS by 6c
July 30, 2020 4:32 PM EDTAllscripts (NASDAQ: MDRX) reported Q2 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $406.2 million versus the consensus estimate of $398.96 million.
Signed definitive agreement to sell EPSi business unit for $365 millionFor earnings history and earnings-related data on Allscripts (MDRX) click here.
... More